STOCK TITAN

Synergy CHC (SNYR) Stock Price, News & Analysis

SNYR NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
77 252 sessions, September 17, 2025 to September 17, 2026
Largest daily move
+233.4% close of September 16, 2026
1-year change
-96% closing prices, September 17, 2025 to September 17, 2026
1-month change
-41.6% closing prices, August 17, 2026 to September 17, 2026

Company Description

Synergy CHC Corp. (NASDAQ: SNYR) is a healthcare-focused consumer products company that develops and markets consumer health and wellness brands. According to its public disclosures, Synergy positions itself as a consumer health and wellness company with a portfolio led by its flagship brands FOCUSfactor® and Flat Tummy®. The company is incorporated in Nevada and its common stock is listed on the Nasdaq Stock Market under the symbol SNYR.

Synergy CHC Corp. focuses on brain health, functional wellness, and women’s wellness and weight management. FOCUSfactor® is described in company materials as a clinically studied brain health supplement and functional beverage line with a long operating history. The brand includes dietary supplements and FOCUSfactor® Focus + Energy ready-to-drink functional beverages and brain-health energy shots. Flat Tummy® complements this portfolio as a lifestyle brand focused on women’s wellness and weight management.

Business model and distribution

Synergy CHC Corp. generates revenue from product sales, as reflected in its financial statements, and has also reported license revenue in prior periods. The company’s disclosures emphasize the marketing and distribution of consumer-branded products in the health and wellness space. FOCUSfactor® has established distribution in the United States, Canada, and the United Kingdom through major retailers. Company press releases note placements with Costco, Walmart, Amazon, BJ’s, Walgreens, and other mass, grocery, pharmacy, convenience, wholesale, and e‑commerce channels.

In addition to supplements, Synergy is building a functional beverage platform around FOCUSfactor® Focus + Energy drinks and brain-health shots. The company has entered into multiple Direct Store Delivery (DSD) partnerships with regional beverage distributors to expand retail availability of its beverages. Examples disclosed in press releases include agreements with Pine State Beverage in Maine, Fuhrer Beverage Company and Banko Beverage Co. in Pennsylvania, C&M Sales in Arkansas, Atlantic Importing Company in Southern New England, and AlaBev in Alabama. These distributors service grocery, convenience, specialty retail, and other outlets across their territories.

Geographic reach and channels

Company communications describe FOCUSfactor® as having an established footprint in the U.S., Canada, and the U.K., with ongoing expansion into additional markets. In North America, Synergy highlights retail authorizations and distribution partnerships with Kroger, Wakefern Food Corp. (parent of ShopRite and The Fresh Grocer), Uniprix in Canada, Fortinos, and Pilot Flying J. Internationally, a partnership with PriceSmart Inc. is expected to bring FOCUSfactor® Focus + Energy beverages to warehouse clubs across Central America, the Caribbean, and Colombia, according to company press releases.

Synergy has also reported the establishment of a wholly owned subsidiary in Mexico and initial shipments of its supplement products to Costco Mexico, as part of an international growth strategy focused on Mexico and broader Latin America. A Director of Sales & Marketing for Mexico & Latin America has been appointed to lead commercial strategy, market expansion, and go‑to‑market execution in that region.

Financial reporting and public company status

Synergy CHC Corp. is a smaller reporting company under U.S. securities laws, as disclosed in its registration statement on Form S‑1. The company files periodic and current reports with the U.S. Securities and Exchange Commission (SEC), including Form 10‑Q, Form 10‑K, and Form 8‑K. In its third quarter 2025 press release, Synergy reported product sales revenue, gross profit, operating income, net income, and non‑GAAP metrics such as EBITDA and Adjusted EBITDA. The company has also disclosed a public offering of common stock completed in August 2025, with proceeds intended for working capital and general corporate purposes.

Synergy’s financial disclosures emphasize ongoing profitability over multiple consecutive quarters, gross margin performance, and changes in working capital, inventory, and liabilities. The company also reports on non‑cash items, foreign currency adjustments, and stock‑based compensation as part of its reconciliation of GAAP to non‑GAAP measures.

Corporate governance and capital structure

Synergy CHC Corp. is incorporated in Nevada. Its SEC filings describe a Board of Directors and standard public company governance structures, including an Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. In 2025, stockholders approved an amendment to the company’s 2024 Equity Incentive Plan to increase the number of shares available for issuance and an amendment to the Articles of Incorporation authorizing up to 1,000,000 shares of preferred stock. The company has also reported changes in board composition and executive roles, such as the appointment of a Head of Strategic Partnerships and a new director with extensive retail and pharmacy OTC experience.

Synergy’s capital structure includes common stock listed on Nasdaq under the symbol SNYR, and it has issued warrants to an underwriter in connection with a public offering, as described in its Form 8‑K. The company has discussed the use of equity incentives and underwriter warrants in its SEC filings and registration statements.

Brand positioning and recognition

Within the consumer health and wellness category, Synergy emphasizes brain health and cognitive performance as a core focus. FOCUSfactor® is described as a clinically studied brain health supplement with formulations aimed at memory, focus, and cognitive clarity. Company press releases state that FOCUSfactor® has a long legacy in the category and has been recognized as the #1 Pharmacist Recommended OTC Memory Supplement for 2025–2026 in a Pharmacy Times survey of pharmacists’ over‑the‑counter recommendations.

Synergy’s communications also highlight its strategy to expand FOCUSfactor® into the functional beverage market, with products positioned around clean energy, mental clarity, and brain‑health benefits. The company describes its beverages as part of the broader trend toward functional wellness and performance‑oriented consumer products. Flat Tummy® is presented as a lifestyle brand that broadens Synergy’s reach into women’s wellness and weight management.

Stock information and investor focus

Investors researching SNYR stock can find details about Synergy CHC Corp.’s operations, risk factors, and financial condition in its SEC filings, including its Form S‑1 registration statement and subsequent reports. The company identifies key risks related to competition in the consumer health and wellness market, reliance on third‑party manufacturers and suppliers, regulatory requirements for nutritional supplements, product safety and quality perceptions, and its ability to execute on expansion plans and maintain brand reputation.

Because Synergy operates in the consumer health and wellness sector with a focus on branded products, its performance is closely tied to retail distribution, brand recognition, and consumer demand for brain health, functional beverages, and women’s wellness products. Public disclosures emphasize the importance of retail partnerships, distribution networks, and international expansion in the company’s growth strategy.

Stock Performance

$0.0905
No recent trading
Last close: September 17, 2026
-96%
1 year to September 17, 2026

Synergy CHC (SNYR) closed at $0.0905 on September 17, 2026. In the 12 months to September 17, 2026, the price lost 96.0%.

See what a $1,000 investment in SNYR would be worth today

Average down calculator for SNYR

SNYR Metrics & Rankings

Price returns through September 17, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Synergy CHC has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, earnings date. View all SNYR news →

Financial Highlights

Synergy CHC generated $30.4M in revenue in FY2025, retaining a 66.8% gross margin, operating income reached -$8.5M (-27.8% operating margin), and net income was -$12.3M, reflecting a -40.6% net profit margin. Diluted earnings per share stood at -$1.27. The company generated -$2.6M in operating cash flow. The current ratio was 1.22, measuring current assets divided by current liabilities.

$30.4M
Revenue (FY2025)
-$12.3M
Net Income (FY2025)
-$2.6M
Operating Cash Flow

Upcoming Events

YEAR
2027
2027 Financial

Increase principal payments

Quarterly principal payments rise to $350,000 under term loan
FEB
10
February 10, 2027 Regulatory

Regain compliance deadline

Nasdaq may grant Synergy CHC until this date to regain compliance with Listing Rule 5250(c)(1) by filing the overdue Form 10-Q.
MAY
2029
May 2029 Financial

Term loan maturity

$20M term loan facility matures with final repayment due

Synergy CHC has 3 upcoming scheduled events. The next event, "Increase principal payments", is expected in 2027. 2 of them are financing or capital events, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the SNYR stock price.

Short Interest History

Last 12 Months

Short interest in Synergy CHC (SNYR) currently stands at 2.2 million shares, up 1189.6% from the previous reporting period. Since November 2025, short interest has increased by 2896.8%.

Days to Cover History

Last 12 Months

Days to cover for Synergy CHC (SNYR) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has decreased by 32%. Across the settlements charted above, it has ranged from 1.0 to 2.7 days.

SNYR Company Profile & Sector Positioning

Synergy CHC (SNYR) operates in the Medical Distribution industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing SNYR often look at related companies in the same sector, including Cosmos Holdings Inc. (COSM), Cellyan Biotechnology Co., Ltd (HKPD), McKesson Corporation (MCK), Cencora, Inc. (COR), and Henry Schein Inc (HSIC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SNYR's relative position within its industry.

Frequently Asked Questions

Synergy CHC (SNYR) has no recent trading. Its last close was $0.0905 on September 17, 2026.

The FY2025 revenue of Synergy CHC (SNYR) is $30.4M, from its most recent completed fiscal year.

The FY2025 net income of Synergy CHC (SNYR) is -$12.3M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Synergy CHC (SNYR) is -$1.27 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Synergy CHC (SNYR) is -$2.6M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Synergy CHC (SNYR) is -40.6% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Synergy CHC (SNYR) is -27.8% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Synergy CHC (SNYR) is 66.8% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Synergy CHC (SNYR), current assets divided by current liabilities, was 1.22 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Synergy CHC (SNYR) is $20.3M for FY2025, its most recent completed fiscal year.

The operating income of Synergy CHC (SNYR) is -$8.5M for FY2025, its most recent completed fiscal year. Learn about operating income.

Synergy CHC Corp. develops and markets consumer health and wellness products. Its portfolio is led by FOCUSfactor®, a clinically studied brain health supplement and functional beverage line, and Flat Tummy®, a lifestyle brand focused on women’s wellness and weight management, according to the company’s public disclosures.

The company highlights two flagship brands: FOCUSfactor®, which includes brain health supplements and Focus + Energy functional beverages and shots, and Flat Tummy®, which is described as a lifestyle brand focused on women’s wellness and weight management.

Synergy reports revenue primarily from product sales of its consumer health and wellness brands. Its financial statements also show license revenue in certain periods, reflecting additional income streams related to its branded products.

Company press releases state that FOCUSfactor® has established distribution in the U.S., Canada, and the U.K. through major retailers such as Costco, Walmart, Amazon, BJ’s, and Walgreens, among others, and through additional mass, grocery, pharmacy, convenience, wholesale, and e‑commerce channels.

According to a company press release, FOCUSfactor® was recognized as the #1 Pharmacist Recommended OTC Memory Supplement for 2025–2026 in a Pharmacy Times survey of pharmacists’ over‑the‑counter recommendations in the memory support category.

Yes. Synergy CHC Corp. is a public company with common stock listed on the Nasdaq Stock Market under the symbol SNYR. It files registration statements and periodic reports with the U.S. Securities and Exchange Commission as a smaller reporting company.

Synergy CHC Corp. is incorporated in Nevada, as disclosed in its SEC filings. The company has authorized common stock and, following stockholder approval, has also authorized up to 1,000,000 shares of preferred stock under its Articles of Incorporation.

Synergy is building a national and international footprint for its FOCUSfactor® Focus + Energy beverages and brain-health shots through Direct Store Delivery partnerships with regional distributors such as AlaBev, Atlantic Importing Company, C&M Sales, Pine State Beverage, Fuhrer Beverage Company, and Banko Beverage Co., as described in its press releases.

The company has highlighted established distribution for FOCUSfactor® in the U.S., Canada, and the U.K., a partnership with PriceSmart to introduce FOCUSfactor® beverages across clubs in Central America, the Caribbean, and Colombia, and the formation of a wholly owned subsidiary in Mexico with initial shipments of supplements to Costco Mexico.

Investors can review Synergy CHC Corp.’s financial statements, risk factors, and other disclosures in its filings with the U.S. Securities and Exchange Commission, including its Form S‑1 registration statement and Form 8‑K reports that furnish quarterly earnings press releases.